Tag: 22nd Century Group

  • 22nd Signs Contract Manufacturing Deal

    22nd Signs Contract Manufacturing Deal

    Photo: www.akolosov.art

    22nd Century Group has signed a significant new contract manufacturing agreement for the production of branded conventional cigarette products. The contract, which will commence revenue generation in the second quarter of 2024, is expected to increase carton production volumes at 22nd Century’s manufacturing facility by more than 20 percent when fully implemented.

    “We are excited to announce this new contract, the first result of our efforts to profitably grow our contract manufacturing business in North Carolina while also working to build our VLN franchise through the development of a new category focused on tobacco harm reduction,” said 22nd Century Chairman and CEO Larry Firestone in a statement.

    In line with the operating targets outlined on our most recent results call, this agreement helps us to scale revenue, improve gross margin and achieve our goal of breakeven operations by the first quarter 2025.”

  • 22nd Century Reports Quarterly Results

    22nd Century Reports Quarterly Results

    Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:”Aptos”,sans-serif; mso-ascii-font-family:Aptos; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Aptos; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual;}

    22nd Century Group reported net revenues of $7.4 million for the quarter that ended Dec. 21, 2023, down from net revenues of $10 million in the comparable 2022 quarter. Gross loss for the fourth quarter was $7.8 million compared with a gross loss of $100,000 in the prior-year period. The loss included a one-time charge of $7.9 million for certain inventory write-down adjustments.

    During the quarter, 22nd Century exited its hemp/cannabis operations to fully focus on tobacco harm reduction and contract manufacturing activities. The company substantially reduced operating costs through efficiency initiatives and the hemp/cannabis business sale. It also began new initiatives to increase sales, improve gross margin and increase operating profit in 2024. Moreover, the company started developing new customer engagement strategies to drive additional sales growth for its VLN low-nicotine cigarettes, which have been authorized by the U.S. Food and Drug Administration.

    “Our turnaround is progressing rapidly after restructuring a significant portion of the business over the last 120 days as part of our mandate to produce stronger future financial results,” said 22nd Century chairman and CEO Larry Firestone in a statement. “Most importantly, cash use has declined rapidly, from a peak run rate of approximately $15 million a quarter last year to less than $4 million projected in the first quarter of 2024, with continued sequential improvement expected in each quarter throughout 2024 as we move further from prior-period cash obligations.”

    Firestone said the company now has two primary areas of focus that both directly pertain to its tobacco market assets. “In the short-term, we will evaluate and profitably grow our contract manufacturing business to cover our operating expenses and mission-critical initiatives around 22nd Century’s very low-nicotine content cigarette technology,” he said. “We will also invest in and grow the VLN brand through sales, customer awareness and capitalizing on a positive regulatory and social environment. With success in these efforts, we believe that 22nd Century can break even by the first quarter 2025.”

  • 22nd Century Slashes Board Compensation

    22nd Century Slashes Board Compensation

    Image: Garry L.

    22nd Century Group today announced a reduction in board compensation expenses expected to save more than $1 million in annual cost for 2024. In addition to the reduced cash compensation structure, the board has also waived any cash compensation due to non-employee directors for the fourth quarter of 2023 and the first quarter of 2024 and voted to forgo any equity compensation grants for directors in 2024.

    “We continue to build on our progress over the past two months as we rapidly turn 22nd Century into a lean operating tobacco business focused on efficiency and value in everything we do,” said 22nd Century Chairman and CEO Larry Firestone in a statement. “These latest changes not only reduce the cash and total compensation cost related to our board, they align the board with our operating philosophy as we seek to become a self-sustaining business through a combination of sales growth, margin improvement and cost reduction.”

    Under the revised compensation structure, adopted with immediate effect, annual independent director compensation will decline from $75,000 to $20,000, audit chair compensation from $20,000 to $10,000, and compensation and nominating & governance chair compensation from $20,000 to $5,000. Compensation for independent directors serving on these committees will be reduced from $10,000 per year to $5,000 per year, and independent board chair compensation, which was previously $50,000 per year, will be replaced with a lead director fee of $20,000 annually. Non-independent members of the board do not receive additional cash compensation for their board service.

  • Firestone to Lead 22nd Century Group

    Firestone to Lead 22nd Century Group

    Photo: Gajus

    22nd Century Group has appointed Lawrence Firestone as its chairman and CEO.

    Firestone brings over 40 years of enterprise, operations and financial management experience in both public and private companies, including tenures as CEO, chief financial officer and chief operating officer across multiple industry sectors. He most recently served as chief financial officer of Oakland Manager, a privately held purveyor of cannabis with both retail and wholesale market penetration, and as chairman of FirePower Technology, a privately held manufacturer of ATX power supplies for the IT and instrumentation markets.

    “Larry is a seasoned executive known for his ‘hands-on’ leadership style emphasizing teamwork, business alignment, continuous improvement, cost control and process optimization. His track record of success with fast growing public companies will serve 22nd Century well as it continues to execute the strategic business plan and work to drive shareholder value,” said Nora Sullivan, former chair of the board, in a statement.

    “I am excited to lead 22nd Century Group as we refocus our current strategic plans built around innovative plant technologies for tobacco harm reduction and new consumer focused health and wellness products,” said Firestone.

    “The team at 22nd Century has created one of the industry’s most innovative integrated tobacco platforms, from plant genetics to fully commercialized disruptive consumer products. I am confident we can build upon the success the company has had to date while developing strategies that can enhance value for shareholders.”

  • 22nd Century Sells Cannabis Operations

    22nd Century Sells Cannabis Operations

    22nd Century Group will sell most of its GVB Biopharma hemp/cannabis operations to Specialty Acquisition Corp., an entity affiliated with GVB employees.

    Terms of the transaction include a cash payment to the company of $1 million at closing of the sale and a 12 percent secured promissory note for $1.25 million issued by the buyer. The company plans to use the proceeds from the sale to further deleverage its balance sheet.

    22nd Century is also entitled to retain any insurance proceeds received in connection with the fire at the company’s Grass Valley manufacturing facility, a portion of which will be used to offset the buyer’s portion of the shared liabilities.

    The sale is expected to close in early December 2023, subject to customary closing conditions, including approval by 22nd Century’s board of directors.

    “The sale of our hemp/cannabis franchise will immediately and materially further reduce the cash and operating demands within our business,” said John Miller, interim CEO of 22nd Century, in a statement.

    “We expect this transaction will substantially lower 22nd Century’s operating expenses beyond the previously announced $15 million in cost savings initiatives on an annual basis. Additionally, we will retain rights to the insurance proceeds, subject to certain offsets, effectively recouping cash that was invested into the continuity of the hemp/cannabis business.

  • 22nd Century Continues VLN Expansion

    22nd Century Continues VLN Expansion

    Photo: 22nd Century Group

    22nd Century Group has expanded its VLN retail presence with more than 500 additional locations across 11 U.S. states.

    With these latest additions, 22nd Century Group’s FDA-authorized VLN reduced nicotine content cigarettes can now be found at more than 5,100 store locations spanning 23 states, including the addition of Washington, Oregon, Kentucky and Louisiana.

    “The addition of over 500 new VLN sales locations has propelled us beyond the noteworthy milestone of 5,100 stores. Our VLN sales presence now extends to 23 states, making VLN available in many of the top markets where smokers reside,” said 22nd Century Group interim CEO John Miller in a statement.

    “VLN is purposefully crafted to offer adult smokers a clinically documented tool to gradually reduce their smoking frequency and mitigate the associated health risks over time. We are pleased that an increasing number of adult smokers now have access to this important product if they are seeking new ways to reduce their smoking habit,” said Miller.

  • Revenues Down, Loss Up for 22nd Century

    Revenues Down, Loss Up for 22nd Century

    Image: Tobacco Reporter archive

    22nd Century Group reported net revenues of $17.81 million in the three months that ended Sept. 30, 2023, down from $19.38 million in the comparable 2022 quarter. Net loss was $72.72 million against a net loss of $13.1 million in the third quarter of 2022.

    “In the third quarter, our VLN footprint expanded from approximately 1,100 stores in 14 states as of June 30, 2023, to over 4,550 stores spanning 19 states. This includes the recent expansion of more than 400 stores in Florida with a leading national convenience store chain that has prior experience in VLN sales across other states,” said 22nd Century Group CEO John Miller in a statement.

    “We also initiated sales in our first nationwide drug store chain, thereby conducting sales trials in five states and diversifying the range of channels through which our products are accessible. However, our dynamic store count growth did not translate into immediate revenue. Sales of VLN were modest in the quarter as the brand is still largely unknown to our target market, and our marketing capabilities are limited given our current financial condition.”

    On Sept. 5, 2023, the company announced its intent to explore strategic alternatives in an effort to maximize shareholder value. While the initial focus was primarily on 22nd Century’s tobacco portfolio, the company subsequently received indications of interest regarding its other assets in addition to tobacco.

    In October, the company reduced the outstanding principal of its senior secured credit facility from approximately $22.1 million to approximately $14 million.

  • 22nd Century Group Reduces Debt

    22nd Century Group Reduces Debt

    Photo: mrmohock

    22nd Century Group has reduced the outstanding principal of its senior secured credit facility from approximately $22.1 million to approximately $14 million as part of an amendment and waiver process with its lenders.

    The reduction reflects a waiver and repayment of the $7.5 million minimum cash balance required under terms of the original debenture agreements, which was held in an escrow account. The company also assigned an existing promissory note pertaining to the company’s previous holdings in Panacea Life Science Holdings as additional consideration in the debt reduction transaction.

    In a nonmonetary exchange, the assigned value of the promissory note was allocated as $600,000 to further principal reduction and $2 million to a reduction in the put price associated with the lender’s outstanding warrants, which portion was subsequently cancelled.

    The remaining principal loan balance of $14 million and the remaining $500,000 of the put price will be due at maturity in 2026 in accordance with the original terms of the debenture agreements. The company was not required to pay any cash to the lenders in connection with this transaction.

    “We continue to actively manage our balance sheet, with a focus on executing our cost reduction initiatives. The reduction in principal amounts owed under the senior secured credit facility as a result of the amendment and waiver will provide for annual cash interest savings of approximately $0.5 million per year,” said Hugh Kinsman, chief financial officer of 22nd Century Group, in a statement.

    Subsequent to the debt reduction, the company announced the consummation of a public offering with $5.25 million in gross proceeds, which will be used for general operating purposes.

  • 22nd Century Launches Public Offering

    22nd Century Launches Public Offering

    22nd Century Group is offering 10 million shares of its common stock and warrants to purchase up to 20 million shares of common stock at a combined public offering price of $0.525 per share and accompanying warrants.

    The warrants have an exercise price of $0.525 per share, are immediately exercisable and will expire five years following the date of issuance. The offering is expected to close on or about Oct. 19, 2023, subject to the satisfaction of customary closing conditions.

    In an announcement, 22nd Century Group said it expects the offering to generate approximately $5.25 million before deducting placement agent’s fees and other offering expenses. The company expects to use the net proceeds of the offering for general corporate purposes.

  • 22nd Century Increases VLN Availability

    22nd Century Increases VLN Availability

    22nd Century Group’s VLN reduced-nicotine content cigarettes are now available at more than 1,200 drug store locations across Texas, Florida, Illinois, North Carolina and Georgia. With this most recent addition, VLN is available in more than 4,000 stores across 16 states compared with approximately 1,100 stores on July 1.

    “We are excited to launch the first drug store chain selling our FDA [Food and Drug Administration]-authorized VLN tobacco harm reduction products, adding 1,200 stores across five key state markets to our growing roster of convenience store points of sale,” said John Miller, interim CEO of 22nd Century Group, in a statement. “VLN offers a new, clinically researched solution helping adult smokers reduce their smoking rate and the associated harms of smoking over time.”

    “VLN users continue to report an overwhelmingly positive experience in our market research, and most say it has helped them reduce consumption of their regular cigarette brand,” said Miller. “Research with VLN users indicates that while most nonprescription methods of quitting or reducing smoking are strongly disliked, more than 75 percent of VLN users say they like their experience with the product. As a result of using VLN, 80 percent of adult consumers report a reduction in usage of their regular brand, and many want to share their positive experience with other adult smokers.”

    VLN is the first and only FDA-authorized combustible cigarette labeled as a tobacco harm reduction product.